ICON CLINICAL RESEARCH LIMITED

Icon Clinical Research Limited is a leading global contract research organisation that partners with biopharma, medical-device and health-technology developers to accelerate the delivery of new therapies. Drawing on deep scientific expertise and a suite of digital tools, ICON offers end-to-end support across the drug-development continuum - from early-phase clinical and bioanalytical services to specialised cardiac-safety monitoring, real-world patient recruitment, and precision-medicine laboratory solutions.

The company's portfolio includes bespoke "blended" solutions that address unique sponsor challenges, AI-enhanced platforms such as EngageAI for real-time customer feedback, and outcome-measure frameworks that focus on evidence-based benefits for patients. ICON also provides dedicated biotech services - due-diligence, asset valuation and market-access advice - as well as guidance on emerging regulatory topics like ICH GCP E6(R3) implementation, joint clinical assessments and AI in software-as-a-medical-device (SaMD). Through webinars, whitepapers and regular insights, ICON helps clients stay ahead of scientific and regulatory trends, making it a trusted partner for innovative drug and device development worldwide.